106 related articles for article (PubMed ID: 18433046)
1. Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation.
Soyama A; Eguchi S; Takatsuki M; Ichikawa T; Moriuchi M; Moriuchi H; Nakamura T; Tajima Y; Kanematsu T
Liver Transpl; 2008 May; 14(5):647-50. PubMed ID: 18433046
[TBL] [Abstract][Full Text] [Related]
2. Routine induction therapy in living donor liver transplantation prevents rejection but may promote recurrence of hepatitis C.
Ghanekar A; Kashfi A; Cattral M; Selzner N; McGilvray I; Selzner M; Renner E; Lilly L; Levy G; Grant D; Greig P
Transplant Proc; 2012 Jun; 44(5):1351-6. PubMed ID: 22664014
[TBL] [Abstract][Full Text] [Related]
3. Living donor liver transplantation to patients with hepatitis C virus cirrhosis.
Sugawara Y; Makuuchi M
World J Gastroenterol; 2006 Jul; 12(28):4461-5. PubMed ID: 16874855
[TBL] [Abstract][Full Text] [Related]
4. Myelopathy due to human T-cell leukemia virus type-1 from the donor after ABO-incompatible liver transplantation.
Wakabayashi T; Obara H; Seki M; Shinoda M; Kitago M; Yagi H; Abe Y; Matsubara K; Yamada Y; Oshima G; Oki K; Nagoshi N; Watanabe K; Hibi T; Itano O; Hoshino K; Suzuki N; Kuroda T; Kitagawa Y
Ann Hepatol; 2019; 18(2):397-401. PubMed ID: 31029562
[TBL] [Abstract][Full Text] [Related]
5. [Case report of HTLV-1 associated myelopathy (HAM) manifested after renal transplantation].
Inose Y; Akiyama S; Mochizuki A; Shimizu Y; Iwata M; Uchiyama S
Rinsho Shinkeigaku; 2010 Apr; 50(4):241-5. PubMed ID: 20411806
[TBL] [Abstract][Full Text] [Related]
6. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M
Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088
[TBL] [Abstract][Full Text] [Related]
7. rs8099917 and viral genotyping as indications for living donor liver transplantation for hepatitis C: a case report.
Yoshida Y; Ikegami T; Yoshizumi T; Toshima T; Yamashita YI; Yoshiya S; Shirabe K; Maehara Y
Transplant Proc; 2014 Sep; 46(7):2426-9. PubMed ID: 25150603
[TBL] [Abstract][Full Text] [Related]
8. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
[TBL] [Abstract][Full Text] [Related]
9. Jaundice developing in a patient with hepatitis C4 months after liver transplantation.
Fiel MI; Schiano T
Hepatology; 2009 Feb; 49(2):695-6. PubMed ID: 19177566
[No Abstract] [Full Text] [Related]
10. Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.
Wiesner RH; Sorrell M; Villamil F;
Liver Transpl; 2003 Nov; 9(11):S1-9. PubMed ID: 14586888
[No Abstract] [Full Text] [Related]
11. Splenic abscess after splenic artery ligation in living donor liver transplantation: a case report.
Balci D; Taner B; Dayangac M; Akin B; Yaprak O; Duran C; Uraz S; Hayzaran S; Ayanoglu O; Killi R; Senturk H; Yuzer Y; Tokat Y
Transplant Proc; 2008 Jun; 40(5):1786-8. PubMed ID: 18589197
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of recurrent hepatitis C virus infection after liver transplantation].
Lengyel G; Tulassay Z
Orv Hetil; 2007 Oct; 148(40):1875-81. PubMed ID: 17905682
[TBL] [Abstract][Full Text] [Related]
13. Human T lymphotropic virus type-1-associated myelopathy manifesting shortly after living-donor renal transplantation.
Nagamine Y; Hayashi T; Kato Y; Horiuchi Y; Tanahashi N
Intern Med; 2015; 54(1):75-8. PubMed ID: 25742898
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C.
Burra P
Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
[TBL] [Abstract][Full Text] [Related]
15. Living donor liver transplantation in patients with hepatitis C.
Zimmerman MA; Trotter JF
Liver Transpl; 2003 Nov; 9(11):S52-7. PubMed ID: 14586896
[TBL] [Abstract][Full Text] [Related]
16. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
[TBL] [Abstract][Full Text] [Related]
17. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-dominant sialadenitis in human T-cell leukemia virus type I-associated myelopathy after living-donor liver transplantation.
Nakamura H; Ichikawa T; Nakamura T; Kawakami A; Iwamoto N; Matsuzaki T; Miyaaki H; Yamasaki S; Ida H; Eguchi S; Hayashi T; Nakao K; Kanematsu T; Eguchi K
Transplant Proc; 2010 Sep; 42(7):2797-9. PubMed ID: 20832591
[TBL] [Abstract][Full Text] [Related]
19. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
20. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
